Cargando…
Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients
BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of suffering from various malignancies. This study aimed to identify specific biomarkers that can detect lung adenocarcinoma (LAC) in T2DM patients for the early diagnosis of LAC. METHODS: The clinical information of ho...
Autores principales: | Yang, Jiayue, Yang, Cheng, Shen, Hong, Wu, Wenjun, Tian, Zhen, Xu, Qinghua, Cao, Cuiping, Ye, Shugao, Ban, Le, Tong, Xin, Mei, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945354/ https://www.ncbi.nlm.nih.gov/pubmed/33691685 http://dx.doi.org/10.1186/s12935-021-01861-8 |
Ejemplares similares
-
A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry
por: Yang, Jiayue, et al.
Publicado: (2021) -
Structural and biophysical characterization of the nucleosome-binding PZP domain
por: Klein, Brianna J., et al.
Publicado: (2021) -
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer
por: Hao, Yi, et al.
Publicado: (2021) -
The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations
por: Klein, Brianna J., et al.
Publicado: (2021) -
Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration
por: Wu, Minhua, et al.
Publicado: (2021)